Medication Interactions: 83 OTC medications That Quietly Interact with Prescription Drugs
Medication Interactions:
Medication interaction is defined as a change in the action of one medication due to the co-administration of another medicine, herb, or food or due to some underlying medical condition. Medication interactions may enhance or depress the effect of the medicines or drugs or they can produce some unexpected effect on the body.
There are a number of medication interactions that are encountered on the daily basis in the medication regimes of the patients but most important of them are the interactions that happened between prescription and OTC medications (medications that can be purchased without a prescription).
OTC medications That Quietly Interact with Prescription Drugs:
When a patient visits a doctor for any chronic condition, the doctor design a proper medication regime for that patient. However afterward, if the patient suffer from any seasonal disease for which OTC medicines are easily available, he may get it from the pharmacy without the consultation with the doctor or the pharmacist. These OTC medications, when co-administered with the prescribed medications for any chronic disease, can interact with the prescribed medication in various ways that can affect the patient’s health severely.
The most important classes of OTC medication to be considered in this regard include antacids, histamine H2 receptor antagonists, NSAIDs, cough and cold preparations and the antiasthma products.
Here are mentioned some most common OTC medications that quietly interact with the prescription drugs:
Note: Availability of medications as OTC drugs, varies from country to country. Each country has its own permitted list of OTC medications.
OTC medication | Prescription Drugs | Risk Associated with Co-administration | ||
Duplication of Medication | ||||
Ibuprofen for headache (non-steroidal anti-inflammatory drugs class) | Naproxen/Diclofenac Sodium or potassium (NSAID class), also prescribed for some other condition. | Ulcer, Gastrointestinal bleeding, renal damage, increase in blood pressure. | ||
Medication Interactions: OTC Painkillers and Prescription Drugs | ||||
Acetylsalicylic acid (ASA) containing pain killers | Warfarin or any other blood thinner | Increases the risk of Bleeding | ||
Carbonic anhydrase inhibitors (acetazolamide) | Increased plasma levels of acetazolamide | |||
Cytotoxics (methotrexate) | Reduced excretion of methotrexate | |||
Corticosteroids | Increased likelihood of stomach irritation and gastro-intestinal bleeding | |||
Uricosurics (sulfinpyrazone) | Reduced uricosuric effects | |||
NSAIDs e.g. Naproxen or diclofenac etc. | Diuretics such as thiazides (e.g., Hydrochlorothiazide), loop diuretics (e.g., Furosemide), and potassium-sparing diuretics (e.g., Spironolactone) ACE inhibitors (ACEIs) such as Captopril, lisinopril, enalapril, and enalaprilat etc and Angiotensin-II receptor blockers such as losartan, valsartan, candesartan, irbesartan, Olmesartan. | NSAIDs can affect reduce the renal blood flow which affect the proper functioning of diuretics and can also decrease the effectiveness of ACEIs and ARBs. Risk of hyperkalaemia is also present. If a person needs to take anti-inflammatory medications (i.e. Ibuprofen, diclofenac or Naproxen) for a few days or a couple of weeks Then ACEI or ARB medications can be stopped for those days after proper consultation with the attending doctor and should be restarted after the patient is done taking the anti-inflammatory pills. Â | ||
Antibacterials (quinolones) | Increased risk of convulsions | |||
NSAIDs (including aspirin), corticosteroids, or anticoagulants | Increased likelihood of stomach irritation or bleeding (NSAIDs, anticoagulants), reduced antiplatelet effects (aspirin) | |||
Methotrexate | Increased toxicity | |||
Lithium | Reduced excretion | |||
Tacrolimus | Increased nephrotoxicity | |||
Hyoscine butyl bromide | Tricyclic antidepressants (e.g. imipramine and clomipramine etc.), antipsychotics (olanzapine, clozapine etc.), antihistamines quinidine, anticholinergics (eg ipratropium, tiotropium) | Intensifies anticholinergic effect e.g. dry mouth, urinary retention, dry eyes and constipation | ||
Paracetamol | Cholestyramine | Reduced absorption of paracetamol | ||
Antiemetics (metoclopramide, domperidone) | Increased rate of absorption of paracetamol | |||
Codeine | Antidepressants, antihistamines, alcohol, antipsychotics, anxiolytics, hypnotics, concurrent opioid analgesics | Increased sedation | ||
Medication Interactions: OTC (Cough and Cold preparations) with Prescribed Medications | ||||
Sedative Anti-histamines e.g. Chlorphenamine Diphenhydramine or doxylamine commonly present in cough and anti-allergy syrups. | Anti-depressants, Anxiolytics (Anti-anxiety medications), Sedatives or Opioids | Extreme sedation and drowsiness can occur as Diphenhydramine causes sedation and drowsiness as a side effect which add to the sedative effect of the Anti-depressants, Anxiolytics (Anti-anxiety medications), or other Sedatives | ||
Diphenhydramine or doxylamine and other first generation anti-histamines also possesses anti-cholinergic effect | Antispasmodics (having anti-cholinergic effects) and anticholinergics (trihexyphenidyl, orphenadrine, urinary anticholinergics), | Â Dry eyes, dry mouth, urinary retention, and constipation. | ||
Doxylamine | Monoamine Oxidase Inhibitors (MAOI) like selegiline, Rasagiline, phenelzine, tranylcypromine and isocarboxazid etc. | Increase the risk of Serotonin syndrome | ||
Loratadine | Antibacterials (erythromycin, clarithromycin), antifungals (ketoconazole), cimetidine | Increased plasma levels of loratadine | ||
Sympathomimetics e.g. Phenylephrine, Pseudoephedrine/ephedrine and xylometazoline (decongestants) mostly present in cough and cold medications | Monoamine Oxidase Inhibitors (MAOI) like selegiline, Rasagiline, phenelzine, tranylcypromine and isocarboxazid etc. | Hypertensive Crisis can occur. A, 14-day washout period is required between stopping an MAOI and starting pseudoephedrine. | ||
Pseudoephedrine/ephedrine (decongestant) mostly present in cough and cold medications | Tricyclic antidepressants (imipramine, clomipramine, desipramine, amitriptyline, nortriptyline, doxepin and amoxapine etc.) | Co-administration can cause increase in blood pressure and problems in heart rhythms. | ||
 | Digitalis | Increased risk of arrhythmias | ||
Dextromethorphan | SSRI (selective serotonin reuptake inhibitors) | Co-administration can cause serotonin syndrome, as dextromethorphan can also increase serotonin level. | ||
Medication Interactions: OTC Gastrointestinal Medications and Prescription drugs | ||||
Proton pump inhibitors | ||||
Omeprazole & Esomeprazole (PPIs: that can inhibit liver enzyme CYP2C19).  | Clopidogrel (An anti-coagulant that requires liver enzyme CYP2C19 for the conversion to its active form) | This inhibition caused by omeprazole decreases the concentration of active clopidogrel by approximately 50%, weakening its effectiveness in preventing blood clots. Esomeprazole also possesses similar effect. However, other PPIs such as lansoprazole, pantoprazole or rabeprazole. inhibit CYP2C19 to a lesser extent. | ||
Citalopram (An anti-depressants that is metabolised by liver enzyme CYP2C19).  | QT prolongation and hyponatremia have been observed due to increase in the concentration of citalopram/Escitalopram. The maximum recommended dose for citalopram is 20mg daily when omeprazole is being co-administered. The dose shouldn’t exceed the recommended limit in order to avoid the side effect. | |||
Levothyroxine | Omeprazole can interfere with the absorption of oral levothyroxine by raising the gastric pH and may reduce its effectiveness. Levothyroxine works best when taken on empty stomach 30-60 min before breakfast. However, the effect of omeprazole last > 24 hours, altering the time of either medication will not avoid the drug-drug interaction. So, proper consultation is required. | |||
Cilostazol | Increased plasma levels of cilostazol | |||
Anxiolytic (Diazepam) | Enhanced effect of diazepam | |||
 | Antifungals (itraconazole, ketoconazole) | Reduced absorption of these drugs | ||
Voriconazole | Increased plasma levels of omeprazole and esomeprazole | |||
Antacids and Adsorbents | ||||
Antacids and Adsorbents | Ketoconazole, chloroquine, penicillamine, and mycophenolate | Reduced absorption of these drugs | ||
Analgesics (aspirin) | Reduced serum salicylate levels and reduced absorption | |||
Some quinolone antibiotics (e.g. ciprofloxacin), rifampicin, tetracyclines, azithromycin, erythromycin | May interfere with absorption or peak levels | |||
Bisphosphonates | Reduced absorption of bisphosphonates | |||
Proguanil | Absorption reduced by magnesium trisilicate | |||
Thiazide diuretics | Increased risk of hypercalcaemia | |||
Tetracycline antibiotics (e.g. doxycycline) | Interferes with absorption of the antibiotic | |||
Anti-Helminthics | ||||
Mebendazole | Carbamazepine, Phenytoin | Lowers plasma mebendazole | ||
Cimetidine | Raises plasma mebendazole | |||
Metronidazole | Increased risk of Stevens-Johnson syndrome | |||
H2-Receptor Blocker | ||||
Ranitidine | Ketoconazole, Atazanavir | Increased absorption of these drugs | ||
Medication Interactions: OTC anti-Malarial medications and prescription Drugs | ||||
Anti-Malarial (Atovaquone) | Tetracycline antibiotics (e.g. doxycycline) | Decreased plasma levels of atovaquone | ||
Metoclopramide | Decreased plasma levels of atovaquone | |||
Medication Interactions: OTC eye drops and prescription Drugs | ||||
Chloramphenicol (topical) Â Â | Bone marrow depressants | Increased bone marrow depression | ||
Medication Interactions: OTC Hair and scalp medications and prescription Drugs | ||||
Topical minoxidil | Other topical scalp medications (corticosteroids, tretinoin, dithranol) | Increased absorption of minoxidil | ||
Medication Interactions: OTC female specific medications and prescription Drugs | ||||
Levonorgestrel | CYP3A4 inducers (rifampicin, phenytoin, carbamazepine, St John’s Wort) | Reduced efficacy of levonorgestrel | ||
Tranexamic acid | Fibrinolytics (streptokinase) | Counteracts thrombolytic effect of fibrinolytics | ||
Ulipristal acetate | CYP3A4 inducers (e.g. rifampicin, phenytoin, carbamazepine, St John’s Wort) | Reduced efficacy of ulipristal | ||
Hormonal contraceptives | May reduce contraceptive action of combined hormonal and progesterone-only contraceptives | |||
Medication Interactions: OTC male specific medications and prescription Drugs | ||||
Sildenafil  | Nicorandil/ Nitrates (e.g. glyceryl trinitrate, isosorbide mononitrate, isosorbide dinitrate) | Increased risk of hypotension | ||
Alpha-blockers (e.g. alfuzosin, doxazosin, tamsulosin) | Increased risk of hypotension | |||
CYP3A4 inhibitors (e.g. ketoconazole, cimetidine, diltiazem, erythromycin, rifampicin, saquinavir) | Increased risk of QT interval prolongation | |||
Tamsulosin  | Antihypertensives e.g. doxazosin, indoramin, prazosin, terazosin, verapamil | Potentiates effect, resulting in dizziness and weakness | ||
Cimetidine, Ketoconazole | Increased plasma levels of tamsulosin | |||
Diclofenac, Warfarin | Increased elimination rate of tamsulosin | |||
Medication Interactions: OTC Anti-migraine medications and prescription Drugs | ||||
Sumatriptan  | MAOIs, ergot alkaloids | Increased risk of coronary vasospasm | ||
St John’s Wort | Increased serotonergic effects and Reduced plasma concentration of sumatriptan | |||
SSRIs | Increased risk of CNS toxicity | |||
Tricyclic antidepressants | Increased side-effects from tricyclic antidepressants | |||
Prochlorperazine maleate  | Lithium | Risk of severe neurotoxicity | ||
Alcohol, CNS depressants (e.g. tramadol, aripiprazole, chlorphenamine) | Additive CNS depressant effect | |||
Antihypertensives (eg ramipril, losartan, sotalol) | Increased risk of hypotension | |||
Alcohol | Increased risk of hypotension | |||
Medication interactions: Smoking cessations medication and prescription drugs | ||||
Nicotine | Anti-arrhythmic (Adenosine) | Action potentiated | ||
Medication Interactions: OTC Vitamins and Supplements with prescription Drugs | ||||
Vitamin A | Retinoids, statins | May increase blood levels of vitamin A, that may lead to chronic hypervitaminosis A | ||
Vitamin B3 (Niacin) | Glimepiride | May increase blood sugar levels; may increase requirements for the drug | ||
Vitamin B6 | Phenobarbital, phenytoin | May reduce drug absorption and effectiveness | ||
 | Levodopa | Vitamin b6 increases the peripheral breakdown of levodopa – decreasing it’s effectiveness | ||
Vitamin C | Aspirin | Reduced vitamin C absorption | ||
Vitamin D | Thiazide diuretics | Increased risk of hypercalcaemia | ||
Antiepileptics (phenytoin) | Reduced serum vitamin D levels | |||
Vitamin E | Aspirin | May increase risk of bleeding | ||
Vitamin K | Anticoagulants (warfarin) | Reduced anticoagulant effects | ||
Agnus Castus  | Dopamine-receptor antagonists | May reduce effectiveness | ||
Dopamine-receptor agonists | Possible potentiation of effect | |||
Calcium  | Thiazide diuretics | Increased risk of hypercalcaemia | ||
Antibacterials (ciprofloxacin, tetracyclines, quinolones), bisphosphonates, nadolol, beta-blockers | May reduce drug absorption | |||
Chromium | Anti-diabetic medications (insulin or sulfonylureas) | Increased risk of hypoglycaemia | ||
Thyroid replacement therapy | May decrease the serum level of levothyroxine. | |||
Co-enzyme Q-10 | Warfarin | May increase metabolism of the drug | ||
 | Antihypertensives | Risk of hypotension due to additive effect. | ||
 | Anti-Cancer Medications | May interfere with the action of anti-cancer medications due to antioxidant effects | ||
Copper | Ciprofloxacin | May reduce drug absorption | ||
Cranberry | Warfarin | May inhibit breakdown of warfarin, leading to increased warfarin activity | ||
Echinacea  | Ciclosporin | May reduce efficacy | ||
Methotrexate | May reduce efficacy | |||
Feverfew | Anticoagulants, antiplatelets, NSAIDs | May increase risk of bleeding | ||
 | Antimigraine medications (e.g. ergotamine) | May increase heart rate and blood pressure because of additive vasoconstrictive effects | ||
Fish oil/cod liver oil (EPA & DHA) | Antihypertensives | May reduce blood pressure | ||
Fish oil/cod liver oil (EPA & DHA) | Anticoagulants, antiplatelets | May increase anti-clotting effects, leading to bleeding | ||
Folic acid  | Antiepileptics (phenobarbital, phenytoin) | May decrease levels of some antiepileptics | ||
Methotrexate | Reduced plasma levels of folic acid | |||
Garlic | Anticoagulants, antiplatelets | May increase anti-clotting effects, leading to bleeding | ||
Antihypertensives | Risk of hypotension due to additive effect | |||
Isoniazid |  Garlic especially in raw form may lowers the level of isoniazid  | |||
Protease inhibitors (e.g. saquinavir) | Blood level of protease inhibitors reduced by raw garlic | |||
Tacrolimus | May increase the blood levels of tacrolimus, possibly enough to cause injury to the liver | |||
Ginger | Anticoagulants (e.g. warfarin) | May increase anti-clotting effects, leading to bleeding | ||
Glucosamine | Anticoagulants (e.g. warfarin) | Enhanced anticoagulant effect | ||
Iodine | Antithyroid | Increased risk of hypothyroidism | ||
Iron | Magnesium trisilicate | Reduced absorption of iron | ||
Iron  | Dopaminergics (levodopa), penicillamine, quinolone antibiotics (eg ciprofloxacin, norfloxacin, ofloxacin), zinc, bisphosphonates, levothyroxine, warfarin | Reduced absorption of these drugs | ||
Tetracycline antibiotics | Reduced absorption of iron and these drugs | |||
Magnesium | Quinolone antibiotics (eg ciprofloxacin, norfloxacin, ofloxacin), tetracycline antibiotics, bisphosphonates | May decrease drug absorption | ||
Misoprostol | Diarrhoea | |||
Zinc | Tetracycline antibiotics, quinolone antibiotics (ciprofloxacin, penicillamine) | Reduced absorption of these drugs | ||
Panax Ginseng  | Imatinib | May increase toxicity of drug | ||
Anticoagulants (e.g. warfarin) | May affect parameters of bleeding | |||
Antihyperglycemic medications (e.g. glipizide) | Risk of hypoglycemia | |||
Aspirin and other NSAIDs | Risk of bleeding | |||
Corticosteroids | May augment the adverse effects of corticosteroids because ginseng has its own anti-inflammatory effects. Ginseng also possesses immunostimulant effects and thus may attenuate the immunosuppressive effects of corticosteroids  | |||
Digoxin | May increase the level of digoxin | |||
Estrogens | May increase the adverse effects of estrogen | |||
MAOIs | Risk of headache, tremors and manic episodes | |||
Opioids | May reduce the effectiveness of opioids | |||
 Gingko biloba | Anticoagulants | Augment the anticoagulant effect: risk of bleeding | ||
Antiseizure medications (e.g. phenytoin) | May reduce the efficacy of antiseizure medications due to the presence of contaminants | |||
Antidepressant medications | Risk of serotonin syndrome | |||
MAOIs (e.g. tranylcypromine) | May intensify effects of MAOIs and increase risk of adverse effects (e.g. headache, tremors, manic episodes) | |||
NSAIDs | Risk of bleeding increases | |||
Green Tea | Atorvastatin Nadolol Warfarin | Green tea may lower the levels and effects of atorvastatin as well as nadolol, thus decreasing the lipid and blood pressure lowering effect of the medications respectively. Green tea may also can reduce the efficacy of warfarin, increasing risk of thromboembolism  | ||
Holy Basil | Thyroid hormones | May attenuate the efficacy of thyroid hormone drugs | ||
Anticoagulants and antiplatelets | May increase risk of bleeding | |||
Licorice (Glycyrriza Glabra) True, natural licorice, not the more common, artificially flavored licorice candy. | Antihypertensives | May increase salt and water retention consequently increasing blood pressure, making antihypertensives less effective | ||
Chemotherapeutics | May lower the efficacy of paclitaxel and cisplatin | |||
Corticosteroids | May increase the adverse effects of corticosteroids | |||
Digoxin | May lowers the potassium level, which increases risk of digoxin toxicity | |||
Diuretics | May intensify the potassium-wasting effects of most diuretics and interfere with the effectiveness of potassium-sparing diuretics such as spironolactone. | |||
MAOIs | May intensify effects of these medications and increase risk of adverse effects (e.g., headache, tremors, manic episodes) | |||
Warfarin | May lower the efficacy of warfarin | |||
Passion flower | Sedatives (e.g. benzodiazepines) | May increase sedative effect | ||
Pelargonium | Anticoagulants (e.g. warfarin) | May increase anticoagulant effect | ||
Potassium | ACE inhibitors, beta-blockers, ciclosporin, potassium sparing diuretics, tacrolimus, co-trimoxazole | Increased risk of hyperkalaemia | ||
Red clover  | Oestrogens | Isoflavones in red clover may increase effect of oestrogens | ||
Anticoagulants (e.g. Warfarin) | Coumarins in red clover may increase risk of bleeding | |||
Valerian | Hypnotics and other sedatives | May increase sedative effect | ||
Turmeric | Anticoagulants or blood thinners | Risk of bleeding as turmeric also possesses anticoagulant effect | ||
Probiotics | Antibiotics | Co-administration of probiotic with antibiotic can decrease the effect of either medications depending upon the situation. So, a gap of at least 2 hours is necessary to have optimal effects of both. | ||
Milk thistle | Insulin | Risk of hypoglycemia | ||
Chamomile  | Oral contraceptives | Decrease in the effect of oral contraceptives: as chamomile possesses estrogenic properties | ||
Anticoagulants or blood thinners | Risk of bleeding as chamomile also possesses blood thinning effect. | |||
Cyclosporine | May increase cyclosporine serum concentrations | |||
Barbiturates and other sedatives | May intensify or prolong effects of sedatives because its volatile oils have additive effects | |||
Iron supplements | May reduce iron absorption via tannins in the plant | |||
Ashwagandha | Anti-diabetics | Risk of hypoglycemia | ||
Anti-hypertensive medications | Risk of hypotension | |||
Immunosuppressants | Interference in the function of immunosuppresants | |||
Sedatives | May increase sedation | |||
Melatonin | Anticoagulants (such as warfarin) | May increase risk of bleeding | ||
Antiseizure medications | May lower the efficacy of antiseizure medications | |||
Benzodiazepines | May increase sedative effect | |||
Methamphetamine | May intensify the adverse effects of methamphetamine | |||
S-adenosyl-L-methionine | Antidepressants | Risk of serotonin syndrome when given with serotonergic medications, manifested by a increase in heart rate, anxiety, gastrointestinal symptoms, severe muscle rigidity, and possible seizures | ||
Levodopa | May lower the efficacy of levodopa | |||
Saw palmetto | Antiplatelets and anticoagulants (e.g., warfarin)Â | Risk of bleeding | ||
Estrogens (eg, oral contraceptives and other products) | May lower the efficacy of estrogens | |||
Valerian | Sedatives (eg, barbiturates, benzodiazepines) | May intensify effects of sedatives | ||
Rhodiola | Antidepressants | Risk of tachycardia | ||
Anticoagulants (e.g., warfarin) | May increase the blood levels of anticoagulants which raises the risk of bleeding | |||
Anti-inflammatory medications | Increased blood levels and possibly adverse effects | |||
Immunosuppressants | May decrease the efficacy of immunosuppressants | |||
Antidiabetic medications | Risk of hypoglycemia | |||
Antihypertensive medications | Risk of hypotension | |||
Reishi | Anticoagulants and antiplatelet medications | Risk of bleeding | ||
Antihypertensives | Risk of hypotension | |||
Antihyperglycemic medications | Risk of hypoglycemia | |||
Kava | Sedatives (e.g., barbiturates, benzodiazepines) | May increase or prolong the effects of sedatives | ||
Antiparkinsonian medications | May antagonize the effects of levodopa and worsen Parkinson disease May reduce metabolism of ropinirole and thus cause dopamine toxicity | |||
Hepatotoxic medications | May increase hepatotoxicity | |||
Goldenseal | Antihypertensives | Berberine present in goldendeal may increase antihypertensive effects | ||
Antidiabetic medications | Berberine content may increase hypoglycemic effects of anti-diabetic medications | |||
Warfarin and heparin | May intensify the effects of warfarin and heparin, increasing risk of bleeding | |||
Astragalus |
| May stimulate the immune system consequently decreasing the effectiveness of immunosuppressants, especially critical after organ transplantation | ||
Lithium | May decrease the elimination of lithium leading to lithium toxicity. | |||
Bacopa | Anticholinergics and the medications that can increase acetylcholine (e.g. glaucoma or Alzheimer disease medications) | May lower the efficacy of anticholinergic medications or intensify the adverse effects of cholinergic medications. | ||
Thyroid hormones | May increase thyroid hormone levels | |||
Medications metabolized by the CYP450 system (e.g. warfarin, calcium channel blockers, antiseizure medications) | May augment the risk of bleeding or lower the blood pressure with calcium channel blockers or sedation with antiseizure medications | |||
Dehydroepiandrosterone | Anticoagulants (e.g., warfarin) | Risk of bleeding | ||
Antidepressants | May trigger mania | |||
Medications with anti-estrogenic effects (e.g. tamoxifen, anastrozole, and fulvestrant) | May lower the efficacy of anti-estrogenic medications | |||
Triazolam (a benzodiazepine). | May increase the sedative effect | |||
Bacille Calmette-Guerin (BCG) vaccine (for tuberculosis) | May decrease the effectiveness of the BCG vaccine | |||
St. John’s wort | Benzodiazepines (eg, alprazolam, lorazepam, diazepam) | May lower the efficacy of benzodiazepines | ||
 | Cyclosporine and tacrolimus | May lowers the blood level of cyclosporine, elevating the risk of organ transplant rejection | ||
 | Digoxin | May decrease the blood level of digoxin, making it less effective leading to severe damage to the patient’s health | ||
 | Iron supplements | May decrease the absorption of iron | ||
 | MAOIs | May increase the effects of MAOIs, possibly causing tremendous increase in blood pressure requiring emergency treatment | ||
 | Ketamine | May decrease the effectiveness of ketamine | ||
 | Nonnucleoside reverse transcriptase inhibitors (e.g., nevirapine, efavirenz) | Potentiate the metabolism of these medications, reducing their efficacy | ||
 | Oral contraceptives | Increases metabolism of oral contraceptives thus reducing their efficacy | ||
 | Oxycodone, methadone, and tramadol | Decreases serum concentrations and consequently the analgesic effects of these medications | ||
 | Phenobarbital | May decrease the effectiveness of phenobarbital | ||
 | Photosensitizing medications (e.g., amiodarone, naproxen, sulphonamide antibiotics) | May increase photosensitivity | ||
 | Protease inhibitors (e.g. indinavir, saquinavir) | May reduce the efficacy of these medications by reducing their blood level. | ||
 | SSRIs (e.g. fluoxetine, paroxetine, sertraline) | May augment effects of these medications | ||
 | Statins (e.g. atorvastatin, lovastatin, rosuvastatin) | May lower the efficacy of statins | ||
 | Tricyclic antidepressants (e.g. desipramine, amitriptyline) | May intensify the effects of tricyclic antidepressants | ||
 | Warfarin and other anticoagulants (e.g., direct-acting oral anticoagulants) | May reduce blood level of warfarin and rivaroxaban, increasing risk of thromboembolism | ||
Medication Interactions: OTC Skin care medications and prescription Drugs | ||||
Clotrimazole (cream) | Latex contraceptives | Reduced effectiveness of latex contraceptives | ||
Tacrolimus | Increased plasma levels of tacrolimus | |||
Oral Fluconazole | Warfarin, phenytoin, theophylline, simvastatin, saquinavir, midazolam & sulphonylureas | Decreased metabolism of these drugs | ||
Hydrochlorothiazide, ritonavir, zidovudine | May lead to hypokalaemia | |||
Rifampicin, phenytoin | Increased metabolism of fluconazole | |||
Warfarin | Increased anticoagulant effect | |||
Medication Interactions: OTC weight loss medications and prescription Drugs | ||||
Orlistat  | Ciclosporin | Reduced absorption of ciclosporin | ||
Oral contraceptives | Decreased effect of oral contraceptives | |||
Fat soluble vitamins (A, D, E, K) | Decreased absorption of fat-soluble vitamins | |||
Antiepileptics | Increased risk of convulsions | |||
Pharma Bulletins & Clinical Knowledge
References
National Cancer Institute. (n.d.). Drug interaction. U.S. Department of Health and Human Services. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/drug-interaction
Hospital News. (n.d.). Common drug interactions with over-the-counter medications. https://hospitalnews.com/common-drug-interactions-with-over-the-counter-medications/
Stahl, S. M. (2021). Mechanism of action of bupropion: A review of its dopamine–norepinephrine reuptake inhibition. CNS Spectrums. https://pmc.ncbi.nlm.nih.gov/articles/PMC8370473/
Stewart Medicine. (n.d.). NSAIDs with ACE inhibitors and ARBs. https://stewartmedicine.com/patient-education/patient-education-2/nsaids-with-aceis-and-arbs/
Specialist Pharmacy Service. (n.d.). Using clopidogrel with proton pump inhibitors (PPIs). NHS. https://www.sps.nhs.uk/articles/using-clopidogrel-with-proton-pump-inhibitors-ppis/
Medsafe. (2014, September). Interaction between omeprazole and citalopram/escitalopram. New Zealand Medicines and Medical Devices Safety Authority. https://www.medsafe.govt.nz/profs/PUArticles/September2014InteractionBetweenOmeprazoleCitalopramEscitalopram.htm
Drugs.com. (n.d.). Levothyroxine and omeprazole drug interactions. https://www.drugs.com/drug-interactions/levothyroxine-with-omeprazole-1463-0-1750-0.html
U.S. News & World Report. (n.d.). Drug interactions you should know about. https://health.usnews.com/otc/articles/drug-interactions-you-should-know-about
OTC Directory. (n.d.). Drug interactions [PDF]. https://www.otcdirectory.co.uk/Drug%20interactions%20PDF.pdf
MSD Manual Professional Version. (n.d.). Ashwagandha. https://www.msdmanuals.com/professional/special-subjects/dietary-supplements/ashwagandha
MSD Manual Professional Version. (n.d.). Some possible dietary supplement–medication interactions. https://www.msdmanuals.com/professional/multimedia/table/some-possible-dietary-supplementmedication-interactions
Disclaimer
This post is for general educational and informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Drug interactions can vary based on the specific medicines, doses, health conditions, and other factors. Always consult a qualified healthcare professional or pharmacist before starting, stopping, or combining medications.

